The implementation of a contract for the supply of vaccine from Coronavirus “Satellite V” in Brazil was conceived to postpone due to the restrictions of the National Agency for Sanitary Supervision (ANVISA). This is reported by TASS with reference to the press service of the Governor of Piaui Wellington Diaz.
The supply contract for the supply of the vaccine concluded by the Consortium of the Northeastern State of Brazil and the Russian Fund of Direct Investments, provided a purchase of 37 million doses of “satellite V”. However, the agreement was suspended in connection with the new constraints of the regulator, as well as the refusal to use the drug within the framework of the national immunization plan and the lack of import permit.
Anvisa put forward demands on the parameters of the national tests of the Russian vaccine, which are different from those that were presented to other foreign drugs. “This causes regret. In Brazil, high mortality is now observed,” the governor’s press service said.
At the same time, dees in a conversation with the TASS earlier noted that it does not understand the reasons for new complications associated with the expansion of the list of approved vaccines. In his opinion, it is necessary to allow the import and use of the “satellite V”. “Which studies talk about its high efficiency in the containment of the” Delta “version,” the politician said.
Earlier, the Doctor of Biological Sciences, Bionanotechnology Remabitoria, Microbiology and Virology of the Novosibirsk State University (NSU), Corresponding Member of the Russian Academy of Sciences, Sergey Netites, stated that the Indian infection was protected by mRNA and vector vaccines. Their key components are viruses, matrix ribonucleic acid and proteins. The effective preparations include the Russian “satellite V”.